Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: Results from the OMEGA study

Clinical Research in Cardiology

Volumn 102, Issue 9, 2013, Pages 671-677

  Liosis, Spyridon ^a   Bauer, Timm ^a   Schiele, Rudolf ^a   Gohlke, Helmut ^c   Gottwik, Martin ^b   Katus, Hugo ^d   Sabin, Georg ^e   Zahn, Ralf ^a   Schneider, Steffen ^b   Rauch, Bernhard ^b   Senges, Jochen ^b   Zeymer, Uwe ^a,b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b Institut fur Herzinfarktforschung   (Germany)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e ELISABETH KRANKENHAUS ESSEN   (Germany)

Author keywords

Acute myocardial infarction; Mortality; Predictors

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 ACID ETHYL ESTER;

ACUTE HEART INFARCTION; AGED; AGING; ARTICLE; COMORBIDITY; CORONARY ARTERY RECANALIZATION; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTION; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT DISCHARGE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84883050385     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0581-2     Document Type: Article

References (30)

1. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349(9064):1498-1504
2. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361(9351):13-20
3. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J et al (1993) A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 328(10):673-679
4. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ (1993) Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med 328(10):685-691
5. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H (1993) A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328(10):680-684
6. Hennekens CH, Albert CM, Godfried SL, Gaziano JM, Buring JE (1996) Adjunctive drug therapy of acute myocardial infarction - evidence from clinical trials. N Engl J Med 335(22):1660-1667
7. Dargie HJ (2001) Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357(9266):1385-1390
8. Califf RM, Pieper KS, Lee KL, Van De Werf F, Simes RJ, Armstrong PW et al (2000) Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation 101(19):2231-2238
9. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J et al (1995) Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 91(6):1659-1668
10. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA et al (2000) TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102(17):2031-2037
11. Singh M, Reeder GS, Jacobsen SJ, Weston S, Killian J, Roger VL (2002) Scores for post-myocardial infarction risk stratification in the community. Circulation 106(18):2309-2314
12. Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E et al (2005) Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45(9):1397-1405
13. Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H et al (2010) OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 122(21):2152-2159
14. Mehta RH, O'Neill WW, Harjai KJ, Cox DA, Brodie BR, Boura J et al (2006) Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions. Am J Cardiol 97(6):817-822
15. Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Marcel Gosselink AT et al (2009) Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coron Artery Dis 20(6):415-421
16. Bae EH, Lim SY, Cho KH, Choi JS, Kim CS, Park JW et al (2012) GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 59(6):795-802
17. Medi C, Montalescot G, Budaj A, Fox KA, Lopez-Sendon J, FitzGerald G et al (2009) Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). JACC Cardiovasc Interv 2(1):26-33
18. Morillas P, Quiles J, Cordero A, Guindo J, Soria F, Mazon P et al (2009) Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol 104(11):1494-1498
19. Salisbury AC, Reid KJ, Spertus JA (2007) Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol 99(5):636-641
20. Bursi F, Vassallo R, Weston SA, Killian JM, Roger VL (2010) Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J 160(1):95-101
21. Addala S, Grines CL, Dixon SR, Stone GW, Boura JA, Ochoa AB et al (2004) Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 93(5):629-632
22. Reil JC, Bohm M (2008) BEAUTIFUL results - the slower, the better? Lancet 372(9641):779-780
23. Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A et al (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376(9744):886-894
24. Amin AP, Spertus JA, Reid KJ, Lan X, Buchanan DM, Decker C et al (2010) The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality. Am Heart J 160(6):1065-1071
25. Stefan MS, Bannuru RR, Lessard D, Gore JM, Lindenauer PK, Goldberg RJ (2012) The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest 141(6):1441-1448
26. Olsson AG, Schwartz GG, Szarek M, Sasiela WJ, Ezekowitz MD, Ganz P et al (2005) High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J 26(9):890-896
27. Duffy D, Holmes DN, Roe MT, Peterson ED (2012) The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction. Am Heart J 163(4):705-713
28. De Luca G, Suryapranata H, van 't Hof AW, de Boer MJ, Hoorntje JC, Dambrink JH et al (2004) Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109(22):2737-2743
29. Dziewierz A, Siudak Z, Rakowski T, Zasada W, Dubiel JS, Dudek D (2010) Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry). Am J Cardiol 106(3):342-347
30. Bakhai A, Ferrieres J, Iniguez A et al (2012) Clinical outcomes, resource use, and costs at 1 year in patients with acute coronary syndrome undergoing PCI: results from the Multinational APTOR Registry. Int Interv Cardiol 25:19-27